ATRC

AtriCure, Inc. (NASDAQ:ATRC) is a medical device company founded in 2000 and headquartered in Mason, Ohio. The company went public in 2005 and has established itself as a leading developer and manufacturer of specialized surgical devices for cardiac tissue ablation and pain management. AtriCure focuses on treating cardiac arrhythmias, particularly atrial fibrillation, and managing post-surgical pain through innovative surgical technologies. The company serves medical centers across the United States, Europe, Asia, and other international markets through both direct sales and independent distributors.